These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2138436

  • 1. Treatment of hay fever with loratadine--a new non-sedating antihistamine.
    Irander K, Odkvist LM, Ohlander B.
    Allergy; 1990 Feb; 45(2):86-91. PubMed ID: 2138436
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A multicentre study of loratadine, clemastine and placebo in patients with perennial allergic rhinitis.
    Frølund L, Etholm B, Irander K, Johannessen TA, Odkvist L, Ohlander B, Weeke B.
    Allergy; 1990 May; 45(4):254-61. PubMed ID: 2143361
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Loratadine (SCH29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of seasonal allergic rhinitis.
    Bruttmann G, Pedrali P.
    J Int Med Res; 1987 May; 15(2):63-70. PubMed ID: 2884152
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action.
    Oei HD.
    Ann Allergy; 1988 Dec; 61(6):436-9. PubMed ID: 2904776
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis.
    Grossman J, Bronsky EA, Lanier BQ, Linzmayer MI, Moss BA, Schenkel EJ, Selner JC.
    Ann Allergy; 1989 Oct; 63(4):317-21. PubMed ID: 2529798
    [Abstract] [Full Text] [Related]

  • 16. Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis.
    Skassa-Brociek W, Bousquet J, Montes F, Verdier M, Schwab D, Lherminier M, Michel FB.
    J Allergy Clin Immunol; 1988 Apr; 81(4):725-30. PubMed ID: 2965719
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis.
    Bédard PM, Del Carpio J, Drouin MA, Yang W, Hébert J, Lavoie A, Prévost M, Turenne Y, PetitClerc C, Lorber R.
    Clin Ther; 1992 Apr; 14(2):268-75. PubMed ID: 1351796
    [Abstract] [Full Text] [Related]

  • 19. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis.
    Horak F, Bruttmann G, Pedrali P, Weeke B, Frølund L, Wolff HH, Christophers E.
    Arzneimittelforschung; 1988 Jan; 38(1):124-8. PubMed ID: 2896508
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.